Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: A randomized, crossover trial
- 1 February 1997
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 130 (2) , 266-273
- https://doi.org/10.1016/s0022-3476(97)70353-6
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Preventing and arresting coronary atherosclerosisAmerican Heart Journal, 1995
- Enhanced low density lipoprotein cholesterol reduction and cost-effectiveness by low-dose colestipol plus lovastatin combination therapyThe American Journal of Cardiology, 1995
- Use of cholestyramine in the treatment of children with familial combined hyperlipidemiaThe Journal of Pediatrics, 1993
- Comparison of the efficacy of Questran light, a new formulation of cholestyramine powder, to regular Questran in maintaining lowered plasma cholesterol levelsThe American Journal of Cardiology, 1991
- Relation of Serum Lipoprotein Levels and Systolic Blood Pressure to Early AtherosclerosisNew England Journal of Medicine, 1986
- Lipid research clinics coronary primary prevention trial: Results and implicationsThe American Journal of Cardiology, 1984
- Low-dose colestipol plus probucol for hypercholesterolemiaThe American Journal of Cardiology, 1984
- LONG-TERM FOLLOW-UP OF CHILDREN WITH FAMILIAL HYPERCHOLESTEROLÆMIA TREATED WITH CHOLESTYRAMINEThe Lancet, 1980
- DOSE-EFFECT RELATION OF CHOLESTYRAMINE IN CHILDREN AND YOUNG ADULTS WITH FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1977
- Use of cholestyramine in treatment of children with familial hypercholesterolaemiaArchives of Disease in Childhood, 1973